Article
Clinical Neurology
Susana Otero-Romero, Luciana Midaglia, Pere Carbonell-Mirabent, Maria Zuluaga, Ingrid Galan, Jordi Rio, Georgina Arrambide, Marta Rodriguez-Barranco, Angela Vidal-Jordana, Joaquin Castillo, Breogan Rodriguez-Acevedo, Ana Zabalza, Carlos Nos, Manuel Comabella-Lopez, Patricia Mulero, Cristina Auger, Jaume Sastre-Garriga, Santiago Perez-Hoyos, Alex Rovira, Xavier Montalban, Mar Tintore
Summary: In this study, the effect of menopause on disability accumulation in women with clinically isolated syndrome (CIS) was evaluated. Results indicated that menopause did not increase the risk of disability in this population when considering Expanded Disability Status Scale (EDSS) trajectories along with age and disease duration. The annual increase in EDSS was higher in menopausal women compared to nonmenopausal women, but this difference disappeared when controlling for age and disease duration.
EUROPEAN JOURNAL OF NEUROLOGY
(2022)
Article
Clinical Neurology
Lauren Astbury, Seema Kalra, Radu Tanasescu, Cris S. Constantinescu
Summary: In this study, the impact of CSF pleocytosis at diagnosis on long-term disease progression in multiple sclerosis patients was investigated. The results showed that CSF pleocytosis was not associated with higher long-term disability and had no long-term prognostic value in routine clinical circumstances.
JOURNAL OF NEUROLOGY
(2023)
Article
Clinical Neurology
Athina-Maria Aloizou, Ioannis Liampas, Antonios Provatas, Alexandros Brotis, Vasileios Siokas, Christos Bakritzis, Panagiotis Liakos, Zisis Tsouris, Efthimios Dardiotis
Summary: This study explored the potential of neurofilament light-chain (NfL) as a prognostic marker in multiple sclerosis (MS). By measuring NfL levels in cerebrospinal fluid and conducting long-term follow-up, the authors found no significant association between NfL levels and age, disability, or severity. However, there was a significant association between older age of onset and disability and severity.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
(2022)
Article
Public, Environmental & Occupational Health
Elisa Baldin, Anne Kjersti Daltveit, Marianna Cortese, Trond Riise, Maura Pugliatti
Summary: This study did not confirm an association between breastfeeding and the risk of developing adult-onset multiple sclerosis, even after adjusting for different durations of breastfeeding and other perinatal factors. The results indicated that breastfeeding information was less likely to be biased by knowledge of disease compared with case-control studies.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
(2021)
Review
Clinical Neurology
Stefan Bittner, Frauke Zipp
Summary: This article discusses current views and concepts for targeting progressive multiple sclerosis (MS). Recent clinical studies have found a closer relationship between relapse-remitting and progressive MS, leading to the introduction of new concepts such as "progression independent of relapse activity". Research on molecular and imaging biomarkers for progressive MS holds promise for identifying high-risk patients at an earlier stage. Novel treatment approaches focus on neuroaxonal protection, myelin regeneration, and modulation of CNS inflammation. Despite some unsuccessful trials, important lessons can still be learned from novel trial designs.
CURRENT OPINION IN NEUROLOGY
(2022)
Article
Immunology
Pablo Arroyo-Pereiro, Lydia Garcia-Serrano, Francisco Morandeira, Blanca Urban, Virginia Mas, Mario Framil, Isabel Leon, Albert Munoz-Vendrell, Elisabet Matas, Lucia Romero-Pinel, Antonio Martinez-Yelamos, Sergio Martinez-Yelamos, Laura Bau
Summary: The potential of kappa-free light chain (kFLC) as a long-term prognostic marker for multiple sclerosis (MS) was explored in this study. The results showed no significant differences in kFLC index between the two groups with different disease courses, indicating that kFLC is unlikely to be a reliable marker for long-term prognosis in MS.
FRONTIERS IN IMMUNOLOGY
(2023)
Article
Biochemical Research Methods
Long Luu, Alan A. Stocker
Summary: The study found that categorical judgments do not directly alter sensory information in working memory, but rather act as top-down expectations in the subsequent sensory recall and inference process. Humans tend to remain consistent with their previous categorical judgments when recalling evidence, leading to various forms of consistency and confirmation biases.
PLOS COMPUTATIONAL BIOLOGY
(2021)
Article
Clinical Neurology
Justine Petitfour, Xavier Ayrignac, Nelly Ginestet, Pauline Prin, Clarisse Carra-Dalliere, Christophe Hirtz, Mahmoud Charif, Sylvain Lehmann, Pierre Labauge
Summary: The study aimed to evaluate the prognostic value of CSF A beta 42 and A beta 40 levels in MS patients. The results showed that CSF amyloid levels were not associated with MS status and disease severity, except for age of patients.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
(2022)
Article
Nursing
Katrina M. Moss, Annette J. Dobson, Leigh Tooth, Gita D. Mishra
Summary: The exclusive breastfeeding rates in Australia are below international targets, and non-exclusive feeding practices include a variety of forms with complex reasons. Factors such as mother's education, weight, smoking, and living location are associated with feeding practices.
JOURNAL OF HUMAN LACTATION
(2021)
Article
Multidisciplinary Sciences
Andrea Hung, Marc Roig, Jenna B. Gillen, Catherine M. Sabiston, Walter Swardfager, Joyce L. Chen
Summary: Research indicates that performing a single session of aerobic exercise immediately before or after motor skill practice may enhance motor learning. Whether individuals are aerobically trained or untrained, there was no significant difference in motor skill retention after exercise. Aerobic fitness level did not appear to modify motor skill retention.
SCIENTIFIC REPORTS
(2021)
Article
Neurosciences
Erik Nutma, Emeline Gebro, Manuel C. Marzin, Paul van der Valk, Paul M. Matthews, David R. Owen, Sandra Amor
Summary: The expression of TSPO in the human central nervous system may reflect cell density rather than activation status of microglia/macrophages. This has implications for interpreting TSPO PET signals in MS and other CNS diseases, highlighting the limitations of extrapolating TSPO biology from rodents to humans.
Article
Medicine, General & Internal
Giuseppina Miele, Simone Cepparulo, Gianmarco Abbadessa, Luigi Lavorgna, Maddalena Sparaco, Vittorio Simeon, Lorenzo Guizzaro, Simona Bonavita
Summary: A study found no significant association between infections and relapses in individuals with multiple sclerosis (MS), suggesting that disease-modifying therapies may reduce the risk of relapse triggered by infections.
JOURNAL OF CLINICAL MEDICINE
(2023)
Review
Biochemistry & Molecular Biology
Olivia Ellen, Sining Ye, Danica Nheu, Mary Dass, Maurice Pagnin, Ezgi Ozturk, Paschalis Theotokis, Nikolaos Grigoriadis, Steven Petratos
Summary: Multiple sclerosis (MS) is a heterogeneous disease characterized by neural tissue loss and dystrophy in the central nervous system. The immune-mediated mechanisms that cause demyelinating lesions during acute episodes are different from those in chronic lesions during progressive MS. This review highlights the molecular and cellular changes associated with neurodegeneration in progressive forms of MS, emphasizing the need for accurate monitoring and new biomarkers to detect and predict progression. Additionally, the review focuses on the modifications required for neurorepair to occur, including changes in the cellular and extracellular environment.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Clinical Neurology
Stefan Bittner, Jiwon Oh, Eva Kubala Havrdova, Mar Tintore, Frauke Zipp
Summary: Blood-based serum neurofilament light chain (sNfL) is being investigated as a biomarker for prognosis and treatment response in multiple sclerosis patients. It reflects ongoing inflammatory-driven neuroaxonal damage and has the potential to guide individualized clinical decision-making.
Review
Clinical Neurology
Sara Collorone, Srikirti Kodali, Ahmed T. Toosy
Summary: The immunoprotective role of pregnancy in multiple sclerosis (MS) has long been recognized, but there is ongoing debate regarding the impact of breastfeeding on disease activity in MS. Limited information on the safety of disease-modifying drugs (DMDs) during the peri-partum period can discourage breastfeeding despite recommendations to exclusively breastfeed for the first 6 months. New evidence suggests that exclusive breastfeeding may protect against disease relapse. Research is shedding light on the hormonal and immunological mechanisms behind relapse risk during pregnancy and postpartum. Furthermore, case reports, real-world data, and clinical trials are contributing to our understanding of the safety of DMDs for the fetus and infant. While some DMDs should be avoided, others may be considered for highly active pregnant or lactating women with MS. This mini-review presents recent evidence on the protective role of exclusive breastfeeding in MS and provides practical considerations for clinicians.
FRONTIERS IN NEUROLOGY
(2023)
Article
Clinical Neurology
Javier Villacieros-Alvarez, Carmen Espejo, Georgina Arrambide, Mireia Castillo, Pere Carbonell-Mirabent, Marta Rodriguez, Luca Bollo, Joaquin Castillo, Manuel Comabella, Ingrid Galan, Luciana Midaglia, Neus Mongay-Ochoa, Carlos Nos, Jordi Rio, Breogan Rodriguez-Acevedo, Jaume Sastre-Garriga, Carmen Tur, Angela Vidal-Jordana, Andreu Vilaseca, Ana Zabalza, Cristina Auger, Alex Rovira, Xavier Montalban, Mar Tintore, Alvaro Cobo-Calvo
Summary: MOG-Ab are rare in adults with a first demyelinating event suggestive of MS. However, it is suggested to determine these antibodies in patients with ON and absence of CSF-OBs based on the results.
ANNALS OF NEUROLOGY
(2023)
Article
Clinical Neurology
Rene Carvajal, Carmen Tur, Xavier Martinez-Gomez, Luca Bollo, Juliana Esperalba, Marta Rodriguez, Agustin Pappolla, Alvaro Cobo-Calvo, Pere Carbonell, Blanca Borras-Bemejo, Jordi Rio, Joaquin Castillo, Nathane Braga, Neus Mongay-Ochoa, Jose Angel Rodrigo-Pendas, Angela Vidal-Jordana, Georgina Arrambide, Breogan Rodriguez-Acevedo, Ana Zabalza, Luciana Midaglia, Ingrid Galan, Manuel Comabella, Jaume Sastre-Garriga, Xavier Montalban, Mar Tintore, Susana Otero-Romero
Summary: A single-dose attempt of VAR and/or MMR vaccines could effectively protect almost two-thirds of patients with multiple sclerosis and reduce delays in immunosuppressive treatment initiation.
MULTIPLE SCLEROSIS JOURNAL
(2023)
Article
Clinical Neurology
Alan J. Thompson, Marcello Moccia, Maria Pia Amato, Peter A. Calabresi, Marcia Finlayson, Annie Hawton, Fred D. Lublin, Ruth Ann Marrie, Xavier Montalban, Michael Panzara, Maria Pia Sormani, Jon Strum, Barbara G. Vickrey, Timothy Coetzee
Summary: The survey results show that stakeholders of multiple sclerosis (MS) believe that the current clinical course descriptors need to change and support a mechanism-driven framework for describing MS. Clinical validation and ease of communication with patients are the most important considerations when developing a new framework.
MULTIPLE SCLEROSIS JOURNAL
(2023)
Article
Clinical Neurology
Amit Bar-Or, Anne H. Cross, Anthony L. Cunningham, Yann Hyvert, Andrea Seitzinger, Hans Guehring, Elise E. Drouin, Nektaria Alexandri, Davorka Tomic, Xavier Montalban
Summary: A post hoc analysis showed that Evobrutinib, an investigational drug for patients with relapsing multiple sclerosis (RMS), has an impact on immune responses. The results suggest that the drug acts as an immunomodulator, inhibiting aberrant immune cell responses while maintaining responsiveness to foreign and recall antigens.
MULTIPLE SCLEROSIS JOURNAL
(2023)
Article
Immunology
Maria Inmaculada Dominguez-Mozo, Ines Gonzalez-Suarez, Luisa Maria Villar, Lucienne Costa-Frossard, Noelia Villarrubia, Yolanda Aladro, Belen Pilo, Xavier Montalban, Manuel Comabella, Ignacio Casanova-Peno, Maria Luisa Martinez-Gines, Jose Manuel Garcia-Dominguez, Maria Angel Garcia-Martinez, Rafael Arroyo, Roberto Alvarez-Lafuente
Summary: Treatment with teriflunomide reduced IgG antibody titers against EBV and HHV-6. Higher levels of EBNA-1 IgG prior to teriflunomide initiation were associated with a better clinical response.
FRONTIERS IN IMMUNOLOGY
(2023)
Article
Immunology
Nicolas Fissolo, Laura Calvo-Barreiro, Herena Eixarch, Ursula Boschert, Luisa M. Villar, Lucienne Costa-Frossard, Mireia Ferrer, Alex Sanchez, Eva Borras, Eduard Sabido, Carmen Espejo, Xavier Montalban, Manuel Comabella
Summary: This study characterized the transcriptomic and proteomic profiles induced by cladribine in blood cells, and identified potential treatment response biomarkers to cladribine in patients with multiple sclerosis.
FRONTIERS IN IMMUNOLOGY
(2023)
Review
Cell Biology
Sunny Malhotra, Mari Carmen Martin Miras, Agustin Pappolla, Xavier Montalban, Manuel Comabella
Summary: Liquid biopsy is a non-invasive method for studying early-stage biomarkers. It involves extracting and analyzing non-solid biological tissues without invasive procedures to determine disease prognosis. Liquid biopsy components, such as extracellular vesicles, microRNAs, and circulating tumor cells, have shown potential as valuable biomarkers in various neurological conditions. This review provides an overview of liquid biopsy and discusses its applications, future directions, and potential limitations.
Meeting Abstract
Clinical Neurology
Rozhin Ashgari, Jutta Gaertner, Stephen Hauser, Amit Bar-Or, Xavier Montalban, Jeffrey Cohen, Derrick Robertson, Anne Cross, Carrie Hersh, Kumaran Deiva, Karlsson Goeri, Ayan Das Gupta, Ronald Zielman, Soudeh Ansari, Bernd Kieseier, Ludwig Kappos
MULTIPLE SCLEROSIS JOURNAL
(2023)
Meeting Abstract
Clinical Neurology
Michael Barnett, Andrew Chan, Huiyu Feng, Kazuo Fujihara, Gavin Giovannoni, Ralf Gold, Xavier Montalban, Fu-Dong Shi, Maria Tintore, Qun Xue, Chunsheng Yang, Hongyu Zhou
MULTIPLE SCLEROSIS JOURNAL
(2023)
Review
Clinical Neurology
Ralf Gold, Michael Barnett, Andrew Chan, Huiyu Feng, Kazuo Fujihara, Gavin Giovannoni, Xavier Montalban, Fu-Dong Shi, Mar Tintore, Qun Xue, Chunsheng Yang, Hongyu Zhou
Summary: Dimethyl fumarate (DMF) is a widely used oral disease-modifying therapy for multiple sclerosis (MS) with proven efficacy and safety. Existing data on DMF are primarily derived from populations outside of Asia. However, recent approval for use in China suggests its relevance to the Chinese population as well.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS
(2023)
Meeting Abstract
Clinical Neurology
Xavier Montalban, Jens Kuhle, Robert Fox, Timothy Vartanian, Dana Horakova, Massimo Filippi, Ernest Roos, Erik Wallstroem, Nazem Atassi
Meeting Abstract
Clinical Neurology
Xavier Montalban, Jerry S. Wolinsky, Douglas L. Arnold, Martin S. Weber, Karolina Piasecka-Stryczynska, Davorka Tomic, Andrea Seitzinger, Hans Guehring
Meeting Abstract
Clinical Neurology
Carmen Tur, Zhaonan Sun, Daniel Bradley, Cynthia Grossman, Xavier Montalban, Alex Rovira, Mar Tintore, Nolan Campbell, Elizabeth Fisher
Meeting Abstract
Clinical Neurology
X. Montalban, J. Kuhle, R. Fox, T. Vartanian, D. Horakova, M. Filippi, E. Roos, V. Nicolas, E. Wallstroem, N. Atassi
MULTIPLE SCLEROSIS JOURNAL
(2023)
Meeting Abstract
Clinical Neurology
X. Montalban, J. S. Wolinsky, D. L. Arnold, M. S. Weber, K. Piasecka-Stryczynska, D. Tomic, A. Seitzinger, H. Guehring
MULTIPLE SCLEROSIS JOURNAL
(2023)